Analysis of the “GSE2034” dataset (n = 285 LNN breast cancer patients) [35] for relapse free survival (RFS) showed that patients with high geminin expression (n = 142) had significantly shorter RFS than low expressing patients (n = 143, HR = 1.37, 95% CI = 1.09–1.74, p = 0.0078, Figure 3K). The gene discussed is GMNN; the disease is breast cancer.